1. At crucial support Zone 2. Current price less than intrinsic value 3. Volumetric profile average is 485 and trading near that level 4. Dividend yield of 5%
Комментарий
⋅
1. It was suggested at 483 , gave move upto 528 . 2. Now its at confluence of 200 and 100 EMA , Pharma is moving in Improvin quadrant in RRG , stay invested , next target 550
Just because it's at it's support level doesn't make it a buy....
TechieindusTrader
⋅
@VivekGolchha, Offcourse .However , You can put 20% of the investment amount , preserved for pharma sector , which would be (X%pharma)(20%GLenmarak)Y% of total investment) , which is safer for Better Risk reward for long term (5 years and above) Horizon.